1.本数据库收录EMA集中程序以及经HMA协调通过互认可程序或分权程序获得批准上市的药品
2.查询欧盟成员国上市的相关信息，点击欧盟成员国上市
掌握医院、零售、 电商 三大终端市场的销售脉搏，就用 药品市场全终端分析系统 (←点击链接免费试用)
全面洞察药品零售数据，助力企业精准决策，把握市场增长，就用穿云众客-零售药品消费分析决策系统(←点击链接免费试用)
| 商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
|---|---|---|---|---|---|---|
| Intanza | influenza vaccine (split virion, inactivated) | J07BB02 | 2009-02-24 | Sanofi Pasteur Europe | Withdrawn | |
| Focetria | influenza vaccine H1N1v (surface antigen, inactivated, adjuvanted) | J07BB02 | 2007-05-02 | Novartis Vaccines and Diagnostics S.r.l. | Expired | |
| Pandemrix | influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) | J07BB02 | 2008-05-20 | GlaxoSmithKline Biologicals S.A. | Expired | |
| Pumarix | pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | J07BB02 | 2011-03-04 | GlaxoSmithKline Biologicals S.A.xa0 | Withdrawn | |
| Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics | prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | J07BB02 | 2010-11-29 | Novartis Vaccines and Diagnostics S.r.l. | Expired | |
| Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals | prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2008-09-26 | GlaxoSmithKline Biologicals S.A. | Withdrawn |
| Daronrix | pandemic influenza vaccine (whole virion, inactivated, adjuvanted) | J07BB01 | 2007-03-21 | GlaxoSmithKline Biologicals S.A. | Lapsed | |
| Aflunov | zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2010-11-28 | Seqirus S.r.l.xa0 | Authorised |
| Fluenz | influenza vaccine (live attenuated, nasal) | J07BB03 | 2024-06-03 | AstraZeneca AB | Authorised | |
| Fluenz | influenza vaccine (live attenuated, nasal) | J07BB03 | 2011-01-27 | MedImmune LLC | Withdrawn | |
| Fluenz Tetra | influenza vaccine (live attenuated, nasal) | J07BB03 | 2013-12-04 | AstraZeneca AB | Authorised | |
| Zoonotic Influenza Vaccine Seqirus | Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted) | J07BB02 | 2023-10-09 | Seqirus S.r.l.xa0 | Authorised | |
| Foclivia | pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2009-10-18 | Seqirus S.r.l.xa0 | Authorised |
| Celldemic | zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) | J07BB02 | 2024-04-19 | Seqirus Netherlands B.V. | Authorised | |
| Flucelvax Tetra | influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | J07BB02 | 2018-12-12 | Seqirus Netherlands B.V. | Authorised | |
| Arepanrix | pandemic influenza vaccine (H1N1)v (split virion, inactivated, adjuvanted) | J07BB02 | 2010-03-23 | GlaxoSmithKline Biologicals S.A. | Withdrawn | |
| Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) | pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | H5N1流感疫苗 | J07BB02 | 2009-10-10 | GlaxoSmithKline Biologicals S.A. | Authorised |
| Pandemic influenza vaccine H5N1 AstraZeneca (previously Pandemic influenza vaccine H5N1 Medimmune) | pandemic influenza vaccine (H5N1) (live attenuated, nasal) | J07BB03 | 2016-05-20 | AstraZeneca AB | Authorised | |
| Supemtek Tetra (previously Supemtek) | quadrivalent influenza vaccine (recombinant, prepared in cell culture) | J07BB02 | 2020-11-16 | Sanofi Winthrop Industrie | Authorised | |
| Fluad Tetra | influenza vaccine (surface antigen, inactivated, adjuvanted) | J07BB02 | 2020-05-20 | Seqirus Netherlands B.V. | Authorised |
